John S. Kovach, President and CEO at LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT), bought 21,100 shares at $4.75 ($100K) on 2020-11-30, disclosed to the SEC on 2020-12-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.